Nimustine

This classification denotes a nitrosourea compound with the molecular formula C9H13ClN6O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0S726V972K, chemically known as urea, n-((4-amino-2-methyl-5-pyrimidinyl)methyl)-n-(2-chloroethyl)-n-nitroso- but more generally known as nimustine, which bears US NIH Compound Identifier 39214. European Medicines Agency schedules Nimustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09299MIG. The term NIMUSTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules nimustine in its Anatomical Therapeutic Chemical (ATC) Classification. NIMUSTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule nimustine under HS 29335995 and SITC 51576. As of Q4 2014, NIMUSTINE remains US FDA's Preferred Term for this commodity. Nimustine bears US NLM identifiers UMLS ID C0028096 and NCI Concept Code C693. SMILES: CLCCN(N=O)C(=O)NCC1C(NC(NC1)C)N.